These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21137033)

  • 1. The absolute quantification of eight inter-α-trypsin inhibitor heavy chain 4 (ITIH4)-derived peptides in serum from breast cancer patients.
    van den Broek I; Sparidans RW; van Winden AW; Gast MC; van Dulken EJ; Schellens JH; Beijnen JH
    Proteomics Clin Appl; 2010 Dec; 4(12):931-9. PubMed ID: 21137033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive liquid chromatography/tandem mass spectrometry assay for absolute quantification of ITIH4-derived putative biomarker peptides in clinical serum samples.
    van den Broek I; Sparidans RW; Schellens JH; Beijnen JH
    Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1842-50. PubMed ID: 20533314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum degradome markers for the detection of breast cancer.
    van Winden AW; van den Broek I; Gast MC; Engwegen JY; Sparidans RW; van Dulken EJ; Depla AC; Cats A; Schellens JH; Peeters PH; Beijnen JH; van Gils CH
    J Proteome Res; 2010 Aug; 9(8):3781-8. PubMed ID: 20557135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry.
    van den Broek I; Sparidans RW; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(5-6):590-602. PubMed ID: 20116351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography/tandem mass spectrometric method for the quantification of eight proteolytic fragments of ITIH4 with biomarker potential in human plasma and serum.
    van den Broek I; Sparidans RW; Schellens JH; Beijnen JH
    Rapid Commun Mass Spectrom; 2008 Sep; 22(18):2915-28. PubMed ID: 18752334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
    Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
    Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lectin-based electrophoretic analysis of the expression of the 35 kDa inter-alpha-trypsin inhibitor heavy chain H4 fragment in sera of patients with five different malignancies.
    Mohamed E; Abdul-Rahman PS; Doustjalali SR; Chen Y; Lim BK; Omar SZ; Bustam AZ; Singh VA; Mohd-Taib NA; Yip CH; Hashim OH
    Electrophoresis; 2008 Jun; 29(12):2645-50. PubMed ID: 18494030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early diagnostic protein biomarkers for breast cancer: how far have we come?
    Opstal-van Winden AW; Vermeulen RC; Peeters PH; Beijnen JH; van Gils CH
    Breast Cancer Res Treat; 2012 Jul; 134(1):1-12. PubMed ID: 22179926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-analytical-related variability influencing serum peptide profiles demonstrated in a mass spectrometry-based search for colorectal and prostate cancer biomarkers.
    Karczmarski J; Rubel T; Mikula M; Wolski J; Rutkowski A; Zagorowicz E; Dadlez M; Ostrowski J
    Acta Biochim Pol; 2013; 60(3):417-25. PubMed ID: 24046818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay.
    Song J; Patel M; Rosenzweig CN; Chan-Li Y; Sokoll LJ; Fung ET; Choi-Miura NH; Goggins M; Chan DW; Zhang Z
    Clin Chem; 2006 Jun; 52(6):1045-53. PubMed ID: 16574760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide profiling in epithelial tumor plasma by the emerging proteomic techniques.
    Caputo E; Lombardi ML; Luongo V; Moharram R; Tornatore P; Pirozzi G; Guardiola J; Martin BM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(1):59-66. PubMed ID: 15797521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proteomic analysis of the plasma glycoproteins of a MCF-7 mouse xenograft: a model system for the detection of tumor markers.
    Orazine CI; Hincapie M; Hancock WS; Hattersley M; Hanke JH
    J Proteome Res; 2008 Apr; 7(4):1542-54. PubMed ID: 18336003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine of patients with early prostate cancer contains lower levels of light chain fragments of inter-alpha-trypsin inhibitor and saposin B but increased expression of an inter-alpha-trypsin inhibitor heavy chain 4 fragment.
    Jayapalan JJ; Ng KL; Shuib AS; Razack AH; Hashim OH
    Electrophoresis; 2013 Jun; 34(11):1663-9. PubMed ID: 23417432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients.
    Høgdall E; Fung ET; Christensen IJ; Yip C; Nedergaard L; Engelholm SA; Risum S; Petri AL; Lundvall L; Lomas L; Høgdall C
    Proteomics Clin Appl; 2010 Dec; 4(12):940-52. PubMed ID: 21137034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique proteolytic fragment of alpha1-antitrypsin is elevated in ductal fluid of breast cancer patient.
    Zhou J; Trock B; Tsangaris TN; Friedman NB; Shapiro D; Brotzman M; Chan-Li Y; Chan DW; Li J
    Breast Cancer Res Treat; 2010 Aug; 123(1):73-86. PubMed ID: 19902353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BIP co-chaperone MTJ1/ERDJ1 interacts with inter-alpha-trypsin inhibitor heavy chain 4.
    Kroczynska B; King-Simmons L; Alloza L; Alava MA; Elguindi EC; Blond SY
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1467-77. PubMed ID: 16271702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of mTRAQ-labeled proteome using full MS scans.
    Kang UB; Yeom J; Kim H; Lee C
    J Proteome Res; 2010 Jul; 9(7):3750-8. PubMed ID: 20465265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
    Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E
    Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidomic Identification of Serum Peptides Diagnosing Preeclampsia.
    Wen Q; Liu LY; Yang T; Alev C; Wu S; Stevenson DK; Sheng G; Butte AJ; Ling XB
    PLoS One; 2013; 8(6):e65571. PubMed ID: 23840341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A strategy for liquid chromatography/tandem mass spectrometry based quantitation of pegylated protein drugs in plasma using plasma protein precipitation with water-miscible organic solvents and subsequent trypsin digestion to generate surrogate peptides for detection.
    Wu ST; Ouyang Z; Olah TV; Jemal M
    Rapid Commun Mass Spectrom; 2011 Jan; 25(2):281-90. PubMed ID: 21192023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.